Basic Calan Sr Information

• INN (International Nonproprietary Name): Verapamil
• Brand Names Available In Canada (English): Isoptin, Isoptin SR, Tarka (combination with trandolapril)
• ATC Code: C08DA01 (Cardiovascular system; Calcium channel blockers; Phenylalkylamine derivatives; Verapamil)
• Forms & Dosages: Immediate‑release tablets 40 mg, 80 mg, 120 mg; Extended‑release tablets/capsules 120 mg, 180 mg, 240 mg
• Manufacturers In Canada (English): Supplied globally by Pfizer (Calan SR in the US) and multiple generics from manufacturers such as Abbott, Mylan, Sandoz; branded products in Canada commonly appear as Isoptin/Isoptin SR and the combination product Tarka
• Registration Status In Canada (English): Marketed products such as Isoptin appear in Canada; verapamil is approved in major jurisdictions for hypertension, angina and supraventricular arrhythmias
• OTC / Rx Classification: Prescription‑only (Rx) medicine

Key Findings From Recent Trials

Major 2022–2025 Canadian & Global Studies

Are you wondering whether extended‑release verapamil still measures up in the latest evidence?

Recent pooled analyses and guideline reviews from 2022 to 2025 emphasise calcium‑channel blockers as effective agents for systolic blood‑pressure lowering and angina symptom control.

Canadian cohort series from 2022–2024 and international meta‑analyses through 2025 that included verapamil reported blood‑pressure reductions comparable to other non‑dihydropyridine calcium‑channel blockers.

Specialist‑managed cohorts using verapamil for supraventricular tachycardia showed acceptable arrhythmia control when treatment occurred under cardiology oversight.

Main Outcomes

Did extended‑release formulations change how patients do on therapy?

Extended‑release (ER/SR) formulations improved adherence and produced more stable 24‑hour blood‑pressure control compared with immediate‑release regimens in real‑world analyses.

In chronic stable angina cohorts, angina frequency and nitroglycerin use declined after switching to appropriately titrated verapamil regimens.

Safety Observations

What safety problems popped up in post‑market and cohort reports?

Safety signals reported in Canadian and international summaries were consistent with established adverse effects such as constipation, bradycardia and ankle oedema.

Drug‑interaction profiles remained important, with monitoring recommended when verapamil is combined with beta‑blockers or digoxin.

Health Canada post‑market surveillance continues routine monitoring and has not produced new class‑wide contraindications beyond existing product monographs.

Clinical Mechanism Of Action

Layman’s Explanation

How does verapamil ease blood pressure and chest pain in plain terms?

Verapamil reduces how strongly the heart squeezes and slows electrical conduction through the atrioventricular (AV) node.

That combination lowers blood pressure and reduces chest pain by decreasing the heart’s oxygen demand.

Extended‑release tablets deliver steady levels so patients get once‑daily control without large peaks and troughs.

Scientific Breakdown

What does verapamil do at a cellular level?

Verapamil is a phenylalkylamine calcium‑channel blocker (ATC C08DA01) that preferentially blocks L‑type calcium channels in cardiac myocytes and vascular smooth muscle.

Its effects are greater on myocardium and AV nodal conduction than on peripheral vasculature, distinguishing it from dihydropyridine agents such as amlodipine.

Electrophysiology Specifics

Why is monitoring needed when using verapamil for rhythm control?

Verapamil slows phase 0 depolarisation in nodal tissue, leading to reduced heart rate and slower AV conduction.

These electrophysiologic actions give it antiarrhythmic utility in supraventricular tachycardia but also create the potential for heart block, so specialist supervision and pulse monitoring are important.

Scope Of Approved & Off‑Label Use

Health Canada Approvals (DIN‑Based)

Which conditions is verapamil approved for in Canada?

Verapamil products are approved in major jurisdictions for hypertension, angina and supraventricular arrhythmias, and in Canada they appear as Isoptin/Isoptin SR and generics that carry a Drug Identification Number (DIN).

Products are prescription‑only and approved dosing aligns with product monographs: hypertension commonly treated with 180–240 mg/day ER, angina often using immediate‑release 80–120 mg three times daily, and arrhythmia regimens typically 240–320 mg/day divided.

Notable Off‑Label Trends In Canadian Practice

Are clinicians using verapamil outside the labelled indications?

Off‑label specialist use for paediatric arrhythmias occurs rarely and is weight‑based under specialist guidance.

Geriatric prescribers often prefer lower starting doses and ER formulations to improve adherence and reduce peak adverse effects.

The combination product Tarka (trandolapril + verapamil) is available and used when a combined ACE inhibitor and verapamil strategy fits the patient’s profile.

Dosage Strategy

General Dosing Per Health Canada Monographs

What dose forms are available and how are they typically started?

Immediate‑release tablets are commonly supplied in 40 mg, 80 mg and 120 mg strengths and are used for acute symptomatic angina and some rhythm control regimens.

Extended‑release tablets and capsules are available in 120 mg, 180 mg and 240 mg strengths for once‑daily or divided dosing, with hypertension maintenance often in the 180–240 mg/day range.

Condition‑Specific Dosing Adjustments

How are doses adjusted for individual conditions?

For hypertension, titrate to effect; many patients are controlled on an ER 180–240 mg once daily regimen.

In angina, immediate‑release dosing (80–120 mg three times daily) provides symptomatic relief, with a switch to ER for maintenance to improve adherence.

Arrhythmia dosing is specialist‑managed at about 240–320 mg/day in divided doses, and abrupt withdrawal should be avoided.

Dose reductions are advised for older adults and those with hepatic impairment, and clinicians should monitor for bradycardia and hypotension during titration.

Safety Protocols

Contraindications (Canadian Advisories)

Who should not take verapamil?

Absolute contraindications include severe hypotension (systolic <90 mmHg), second‑ or third‑degree AV block unless a pacemaker is present, sick sinus syndrome without a pacemaker, severe heart failure and known hypersensitivity to verapamil or excipients.

Use in pregnancy and breastfeeding is generally avoided unless the potential benefit outweighs risk, following specialist advice.

Adverse Effects (Post‑Market Reports)

What side effects do Canadian patients typically report?

Constipation is the most commonly reported adverse effect, followed by dizziness, headache, fatigue, peripheral oedema and nausea.

Bradycardia is a clinically important effect and should prompt pulse and blood‑pressure checks during initiation and up‑titration.

Pharmacists commonly counsel patients on constipation management strategies and on when to seek medical attention for slow pulse or symptoms of hypotension.

Interaction Mapping

Food Interactions Common In Canadian Diet

Can foods change how verapamil works?

Grapefruit and grapefruit juice can increase systemic verapamil exposure by inhibiting intestinal CYP3A4, so advise patients to avoid or minimise grapefruit products.

Dietary calcium supplements may blunt the antihypertensive effect; discuss timing so that calcium doses do not coincide with verapamil dosing where practical.

Drug Combinations Flagged By Health Canada

Which drugs require pharmacist review before combining with verapamil?

Combining verapamil with beta‑blockers carries an additive risk of AV conduction depression and bradycardia; close monitoring and specialist review are recommended.

Verapamil can raise digoxin levels—monitor digoxin concentrations and adjust dose if needed.

CYP3A4 inhibitors such as certain macrolide antibiotics and azole antifungals can increase verapamil exposure, and verapamil may increase exposure of some statins like simvastatin, so consider alternatives or dose adjustments.

Always check provincial drug interaction resources and consult a pharmacist when adding or stopping interacting medicines.

Patient Experience Analysis

Canadian Survey Data

What do patients tell pharmacists about taking verapamil?

Surveys and counselling logs in Canada show higher satisfaction with once‑daily ER/SR formulations for convenience and smoother blood‑pressure control.

Constipation and fatigue remain the leading causes of early discontinuation, and elderly patients commonly request dose adjustments to improve tolerability.

Forum & Community Pharmacy Trends

What are common questions at the pharmacy counter or online forums?

Frequent topics include brand versus generic interchangeability (for example, Isoptin SR versus generics), bilingual labelling on packaging, and whether ER tablets can be split—patients are advised not to crush or chew extended‑release forms.

Pharmacists in national chains routinely educate on missed‑dose rules, interaction checks and practical measures to manage constipation and dizziness.

Distribution & Pricing Landscape

National Pharmacy Chains

Where do most Canadians find verapamil?

Verapamil ER/SR and generics are widely stocked in major Canadian chains such as Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs, though availability varies by brand and province.

Isoptin SR is commonly present, and pharmacies will dispense DIN‑listed generics as preferred by provincial formularies.

Online Pharmacy Availability & Provincial Restrictions

Can Canadians order verapamil online?

Licensed Canadian online pharmacies supply verapamil by prescription and require a valid prescription for dispensing.

Provincial rules may restrict mail‑order for certain medications and coverage depends on provincial formularies such as the Ontario Drug Benefit, BC PharmaCare and RAMQ, plus private insurance plans.

In our online pharmacy, calan sr is available by prescription, with discreet delivery to Canada (English) in 5–14 days.

Cross‑Border US Comparisons

Do prices differ versus the United States?

Retail prices in Canada can be higher or lower than US cash prices depending on brand and generic status and on insurance coverage; some Canadians compare US prices near the border but must respect import restrictions and prescription rules.

Alternative Options

Comparison Of DIN‑Approved Alternatives

What are common alternatives to verapamil in Canada?

Key Canadian alternatives include diltiazem (Cardizem, Tiazac), amlodipine (Norvasc) and beta‑blockers such as atenolol and metoprolol.

Diltiazem shares similar AV nodal effects to verapamil, while amlodipine is a dihydropyridine with stronger vasodilatory action and less AV nodal depression.

Pros And Cons Checklist

How do you choose among them?

• Verapamil pros: strong AV‑nodal control, antiarrhythmic utility, ER formulations that aid adherence.
• Verapamil cons: constipation, bradycardia risk and multiple drug interactions.
• Amlodipine pros: potent BP lowering, once‑daily dosing; cons: reflex tachycardia and peripheral oedema.

The optimal choice depends on the indication, comorbidities and interaction profile for each patient.

Regulatory Status

Health Canada Approval Process

What does Health Canada require before a product reaches Canadian shelves?

Verapamil products are authorised by national regulators after submission of safety, efficacy and quality data, and each marketed product receives a Drug Identification Number (DIN) and a product monograph.

Clinical use should follow approved indications and monograph dosing, with post‑market vigilance maintained by regulatory authorities.

DIN And Bilingual Labelling Rules

How does packaging work in Canada?

Canadian regulation requires bilingual labelling (English and French) on packaging and patient information leaflets.

Pharmacists verify the DIN for formulary adjudication and reimbursement under programs such as the Ontario Drug Benefit, BC PharmaCare and RAMQ.

Consolidated FAQ

What are the quick answers patients ask most?

• Can I crush Calan SR/Isoptin SR? No — do not crush or chew extended‑release forms; swallow whole to avoid dose dumping.
• Is verapamil covered by provincial drug plans? Coverage varies; check Ontario Drug Benefit, BC PharmaCare and RAMQ formularies for preferred brands and prior authorisations.
• What should I do if I miss a dose? Take as soon as you remember unless it is almost time for the next dose; do not double dose.
• Can I take verapamil with a beta‑blocker? It can be possible but requires close monitoring because of increased risk of AV block and bradycardia; specialist or pharmacist review is recommended.
• Is grapefruit juice allowed? Avoid grapefruit products because they can increase verapamil levels.

Visual Guide

Which visuals help patients and clinics most?

Recommended infographics include a dosage flowchart that differentiates ER versus IR choices by indication — for example, hypertension commonly 180–240 mg ER once daily, angina acute control with IR 80–120 mg TID and arrhythmia dosing 240–320 mg/day under specialist care.

A provincial coverage map is useful to show Ontario Drug Benefit, BC PharmaCare and RAMQ variances and typical DIN or prior‑authorisation requirements.

A purchase channel graphic should compare in‑store availability (Shoppers, Rexall, Jean Coutu, London Drugs) versus licensed online pharmacies, with a checklist for prescriptions and bilingual labelling.

Design notes: use clear icons for contraindications, interaction warnings (grapefruit, beta‑blockers), and a prominent “Do Not Crush” symbol for ER products.

Storage & Transport

Canadian Household Guidelines

How should patients store verapamil at home?

Store tablets and capsules at room temperature between 15–30°C, away from moisture and heat, and keep them out of reach of children.

Pharmacists advise keeping medication in the original labelled container so bilingual labelling and DIN information remain visible.

Cold‑Chain Storage Where Applicable

Does verapamil need refrigeration?

No cold‑chain storage is required for oral verapamil formulations.

When travelling, maintain room‑temperature conditions, avoid prolonged heat exposure and carry a copy of the prescription or dispensing label when crossing provincial borders or flying.

Guidelines For Proper Use

Advice From Canadian Pharmacists

What practical counselling should pharmacists provide?

Start older adults at lower doses, emphasise “do not crush/chew ER” and review all prescriptions for interacting drugs such as digoxin, beta‑blockers and CYP3A4 inhibitors.

Counsel on constipation management, advise on signs of bradycardia or hypotension, verify DIN for provincial plan coverage and give bilingual patient leaflets where available.

Provincial Health Authority Guidance

What monitoring is recommended after starting verapamil?

Provincial therapeutic bulletins advise monitoring pulse and blood pressure after initiation and titration, reducing doses in hepatic impairment, and referring to specialists when initiating therapy for arrhythmias.

For reimbursement, follow provincial formularies and prior‑authorisation processes when required.

Delivery Across Canada (English)

Practical Case Examples

Worried about what happens at the pharmacy counter?

Example 1: A 72‑year‑old patient with hypertension and constipation asked for help switching to an ER formula.

The pharmacist recommended starting verapamil ER 120 mg once daily and increasing slowly while offering fibre, hydration and stool softener advice to manage constipation.

Pulse and blood pressure were checked after each dose increase, and dose reduction was implemented when bradycardia developed.

Example 2: A 58‑year‑old with chronic stable angina wanted fewer tablets each day.

The cardiologist switched immediate‑release 80 mg TID to an ER regimen targeting an equivalent daily dose and arranged follow‑up for symptom review.

Quick Safety Checklist For Pharmacists

Need a fast screening list before dispensing?

• Confirm blood pressure and pulse baseline and after dose changes.
• Check for contraindications: advanced AV block, sick sinus syndrome, severe hypotension, severe heart failure.
• Review interacting medications: beta‑blockers, digoxin, CYP3A4 inhibitors, certain statins.
• Advise: Do not crush or chew ER forms; avoid grapefruit juice; monitor for constipation and bradycardia.

Final Notes On Counseling And Follow‑Up

What should every patient know before leaving the pharmacy?

Explain the difference between ER/SR and IR formulations and reinforce the “do not crush/chew” instruction for extended‑release tablets or capsules.

Provide written bilingual instructions when possible and advise patients to carry a copy of their prescription when travelling between provinces.

Encourage patients to report constipation, dizziness or unusually slow heart rate promptly, and to consult their prescriber before starting new medicines such as macrolide antibiotics, azole antifungals or certain statins.

References And Where To Learn More

Where can clinicians check product details and monographs?

Refer to the product monograph and provincial formularies for DIN‑specific dosing, contraindications and reimbursement details.

For interactions and laboratory monitoring recommendations consult standard drug interaction resources and provincial pharmacy practice bulletins.

Closing Practical Tip

Looking for a refill or brand switch?

Ask the pharmacist to verify the DIN for your provincial plan, confirm whether an interchange to a generic ER product is appropriate, and request counselling on missed‑dose rules and interaction checks.

Remember that verapamil is prescription‑only and that any change in formulation or dose should be supervised by the prescriber and pharmacist to maintain safe rhythm control and blood‑pressure management.